[go: up one dir, main page]

WO2005091804A3 - Paramyxovirus family inhibitors and methods of use thereof - Google Patents

Paramyxovirus family inhibitors and methods of use thereof Download PDF

Info

Publication number
WO2005091804A3
WO2005091804A3 PCT/US2005/004565 US2005004565W WO2005091804A3 WO 2005091804 A3 WO2005091804 A3 WO 2005091804A3 US 2005004565 W US2005004565 W US 2005004565W WO 2005091804 A3 WO2005091804 A3 WO 2005091804A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
paramyxovirus
family inhibitors
paramyxovirus family
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2005/004565
Other languages
French (fr)
Other versions
WO2005091804A2 (en
Inventor
Richard K Plemper
Richard W Compans
James P Snyder
Aiming Sun
Dennis C Liotta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emory University
Original Assignee
Emory University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emory University filed Critical Emory University
Publication of WO2005091804A2 publication Critical patent/WO2005091804A2/en
Publication of WO2005091804A3 publication Critical patent/WO2005091804A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Methods of treating paramyxovirus , vaccines for protecting against paramyxovirus, and pharmaceutical composition including a paramyxovirus inhibitor compound or composition, are described.
PCT/US2005/004565 2004-02-11 2005-02-11 Paramyxovirus family inhibitors and methods of use thereof Ceased WO2005091804A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54352104P 2004-02-11 2004-02-11
US60/543,521 2004-02-11

Publications (2)

Publication Number Publication Date
WO2005091804A2 WO2005091804A2 (en) 2005-10-06
WO2005091804A3 true WO2005091804A3 (en) 2006-04-20

Family

ID=35056640

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/004565 Ceased WO2005091804A2 (en) 2004-02-11 2005-02-11 Paramyxovirus family inhibitors and methods of use thereof

Country Status (1)

Country Link
WO (1) WO2005091804A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8729059B2 (en) * 2007-02-09 2014-05-20 Emory University Paramyxovirus family inhibitors and methods of use thereof
WO2020099383A1 (en) 2018-11-13 2020-05-22 Janssen Vaccines & Prevention B.V. Stabilized pre-fusion rsv f proteins
CN115461076A (en) * 2020-04-02 2022-12-09 扬森疫苗与预防公司 Stabilized vaccine composition
EP4603477A1 (en) * 2024-02-16 2025-08-20 Consejo Superior De Investigaciones Científicas Inhibitors of the coronavirus accessory protein orf9b

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4835168A (en) * 1985-12-16 1989-05-30 Eli Lilly And Company Thiadiazole antiviral agents
US6043276A (en) * 1998-06-25 2000-03-28 Georgetown University School Of Medicine Compounds obtained from salvia species having antiviral activity
US20030187063A1 (en) * 2001-03-08 2003-10-02 Pooran Chand Compounds useful for inhibiting paramyxovirus neuraminidase

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4835168A (en) * 1985-12-16 1989-05-30 Eli Lilly And Company Thiadiazole antiviral agents
US6043276A (en) * 1998-06-25 2000-03-28 Georgetown University School Of Medicine Compounds obtained from salvia species having antiviral activity
US20030187063A1 (en) * 2001-03-08 2003-10-02 Pooran Chand Compounds useful for inhibiting paramyxovirus neuraminidase

Also Published As

Publication number Publication date
WO2005091804A2 (en) 2005-10-06

Similar Documents

Publication Publication Date Title
WO2008127275A3 (en) Pyrrolinone compounds as inhibitors of bacterial peptidyl trna hydrolase and uses thereof
WO2006066133A3 (en) Histone deacetylase inhibitors
WO2007125310A3 (en) Pharmaceutical combinations of pk inhibitors and other active agents
WO2009099596A3 (en) Macrocyclic serine protease inhibitors
WO2008073452A8 (en) Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors
WO2006071762A3 (en) Pyrimidine-based inhibitors of dipeptidyl peptidase iv and methods
WO2007139860A3 (en) Heterobicylic metalloprotease inhibitors
WO2009082701A8 (en) Hcv protease inhibitors and uses thereof
WO2007084390A3 (en) Histone deacetylase inhibitors
WO2008063671A3 (en) Heterobicyclic metalloprotease inhibitors
WO2008016883A3 (en) Inhibitors of plasma kallikrein
WO2008055068A3 (en) Inhibitors of histone deacetylase
WO2006078752A3 (en) Inhibitors of dna methyltransferase
WO2007059230A3 (en) Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors
CL2007000918A1 (en) COMPOUNDS DERIVED FROM ENFUMAFUNGINA, INHIBITORS OF (1,3) -BETA-D-GLUCANOSINTETASE; PHARMACEUTICAL COMPOSITION; AND USE TO TREAT A FUNGICAL INFECTION.
WO2008042480A3 (en) Epoxide inhibitors of cysteine proteases
WO2007109105A3 (en) Flavivirus inhibition by sultams and related compounds
WO2005084654A3 (en) Methods and compositions for treating or preventing psychiatric disorders with cox-2 inhibitors alone and in combination with antidepressant agents
WO2008048121A3 (en) Macrocyclic cysteine protease inhibitors and compositions thereof
WO2007099171A3 (en) Bicyclo-pyrazoles active as kinase inhibitors
WO2008098239A3 (en) Paramyxovirus family inhibitors and methods of use thereof
WO2006124684A3 (en) Combination therapy comprising a taxane and a thymidylate synthase inhibitor
NO20076566L (en) New method for the treatment of hyperlipidemia
WO2005041904A3 (en) Inhibitors of coronavirus protease and methods of use thereof
WO2005091804A3 (en) Paramyxovirus family inhibitors and methods of use thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase